Alpha 2.0
Login Register
» Authors » Paul Monagle

Paul Monagle

Explore the profile of Paul Monagle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 270
Citations 2936
Followers 0
Related Specialties
Hematology
Pediatrics
Cardiology & Vascular Diseases
Top 10 Co-Authors
Vera Ignjatovic
Fiona Newall
Chantal Attard
Christoph Male
Suelyn Van Den Helm
Mark T MacKay
Conor McCafferty
Natasha Letunica
Vasiliki Karlaftis
Graeme MacLaren
Published In
Thromb Res
J Paediatr Child Health
Thromb Haemost
Res Pract Thromb Haemost
Pediatr Crit Care Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Hemostatic Outcome Definitions in Pediatric Extracorporeal Membrane Oxygenation: Challenges in Cohorts From Rotterdam (2019-2023) and Melbourne (2016-2022)
Drop J, Van Den Helm S, Letunica N, Wildschut E, de Hoog M, de Boode W, et al.
Pediatr Crit Care Med . 2025 Mar; 26(3):e315-e323. PMID: 40048299
Objectives: To determine if a priori standardization of outcome hemostatic definitions alone was adequate to enable useful comparison between two cohorts of pediatric extracorporeal membrane oxygenation (ECMO) patients, managed according...
2.
Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT
Stevens H, McFadyen J, Mellett N, Lynn D, Duong T, Giles C, et al.
Res Pract Thromb Haemost . 2025 Mar; 9(1):102677. PMID: 40041449
Background: VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such as ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with...
3.
Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2
Corocher T, Edwards K, Hersusianto Y, Campbell D, Lim H, Monagle P, et al.
PLoS One . 2025 Feb; 20(2):e0316700. PMID: 39913533
Carrageenan-containing nasal sprays, available over-the-counter (OTC), are often marketed as having anti-viral effects. Carrageenan belongs to the glycosaminoglycan family alongside heparin, and heparin is known to inhibit real-time quantitative polymerase...
4.
Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatment
Betensky M, Albisetti M, Biss T, Bhat R, Brandao L, Diacovo T, et al.
J Thromb Haemost . 2025 Jan; PMID: 39798923
Background: The pediatric direct oral anticoagulation (DOAC) trials provide an opportunity to evaluate and characterize challenges in their design and execution to inform future antithrombotic trials. Objectives: To perform a...
5.
Continuous reference intervals for holotranscobalamin, homocysteine and folate in a healthy paediatric cohort
Smith J, Karlaftis V, Hearps S, Attard C, Savoia H, Campbell J, et al.
Ann Clin Biochem . 2024 Aug; 61(6):469-473. PMID: 39163146
Background: The detection of deficiencies in B and folate children is important. However, despite the availability of various markers to assess B and folate metabolism, there are limited studies describing...
6.
Comprehensive Characterization of Surface-Bound Proteins and Measurement of Fibrin Fiber Thickness on Extracorporeal Membrane Oxygenation Circuits Collected From Patients
Cai T, Emery-Corbin S, McCafferty C, Van Den Helm S, Letunica N, Attard C, et al.
Pediatr Crit Care Med . 2024 Aug; 25(11):1017-1025. PMID: 39145643
Objective: To characterize surface-bound proteins and to measure the thickness of fibrin fibers bound to extracorporeal membrane oxygenation (ECMO) circuits used in children. Design: Single-center observational prospective study, April to...
7.
Characterization of Protein Binding on an Extracorporeal Membrane Oxygenation (ECMO) Circuit Following the Priming Procedure
Cai T, Emery-Corbin S, McCafferty C, Van Den Helm S, Letunica N, Barton R, et al.
ASAIO J . 2024 Jul; PMID: 39008796
No abstract available.
8.
Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)
Ullman A, Takashima M, Gibson V, Comber E, Borello E, Bradford N, et al.
BMJ Open . 2024 Jul; 14(7):e085637. PMID: 38986559
Introduction: Central venous access devices (CVADs) are commonly used for the treatment of paediatric cancer patients. Catheter locking is a routine intervention that prevents CVAD-associated adverse events, such as infection,...
9.
Anticoagulation Monitoring and Targets: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference
Ozment C, Alexander P, Chandler W, Emani S, Hyslop R, Monagle P, et al.
Pediatr Crit Care Med . 2024 Jul; 25(7 Suppl 1):e14-e24. PMID: 38959356
Objectives: To derive systematic-review informed, modified Delphi consensus regarding anticoagulation monitoring assays and target levels in pediatric extracorporeal membrane oxygenation (ECMO) for the Pediatric ECMO Anticoagulation CollaborativE. Data Sources: A...
10.
Anticoagulant Medications: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference
Cashen K, Saini A, Brandao L, Le J, Monagle P, Moynihan K, et al.
Pediatr Crit Care Med . 2024 Jul; 25(7 Suppl 1):e7-e13. PMID: 38959355
Objectives: To derive systematic-review informed, modified Delphi consensus regarding the medications used for anticoagulation for pediatric extracorporeal membrane oxygenation (ECMO) for the Pediatric ECMO Anticoagulation CollaborativE (PEACE). Data Sources: A...